Cancer risk after renal transplantation in Japan

International Journal of Cancer

Volumn 71, Issue 4, 1997, Pages 517-520

  Hoshida, Yoshihiko ^a   Tsukuma, Hideaki ^b   Yasunaga, Yutaka ^a   Xu, Ning ^a   Fujita, Masaki Q ^a   Satoh, Takaomi ^c   Ichikawa, Yasuji ^d   Kurihara, Kenji ^e   Imanishi, Masaaki ^f   Matsuno, Tsuyoshi ^g   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c Sendai Shakaihoken Hospital   (Japan)

^d Hyogo Prefectural Nishinomiya Hospital   (Japan)

^e Uwajima City Hospital   (Japan)

^f KINKI UNIVERSITY   (Japan)

^g OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; ARTICLE; CANCER RISK; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; KIDNEY CANCER; KIDNEY TRANSPLANTATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID CANCER; UTERUS CANCER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CARCINOMA, RENAL CELL; CHILD; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; JAPAN; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RISK; SEX DISTRIBUTION;

EID: 0344388471     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970516)71:4<517::AID-IJC3>3.0.CO;2-X     Document Type: Article

References (16)

1. BAILAR, J.C. and EDERER, F., Significance factors for the ratio of a Poisson variable to its expectation. Biometrics, 20, 639-643 (1954).
2. BIRKELAND, S.A. and 18 OTHERS, Cancer risk after renal transplantation in the Nordic countries. 1964-1986. Int. J. Cancer, 60, 183-189 (1995).
3. GAYA, S.B.M., REES, A.J., LECHLER, R.I., WILLIAMS, G. and MASON, P.D., Malignant disease in patients with long-term renal transplants. Transplantation 59, 1705-1709 (1995).
4. GARDNER, M.J., GARDNER, S.B. and WINTER, P.D., Confidence-Interval analysis (CIA). Brit. med J.,46-56 (1989).
5. GUNJI, Y., OCHIAI, T., ASANO, T., SUZUKI, T., ENOMOTO, K., HORI, S., SHIMADA, H., YASUMOTO, A. and ISONO, K., Development of malignant tumor in renal-transplant recipients and their NK and LAK activity. Jap. J. Clin. Immun.,13, 236-245 (1990). (In Japanese).
6. INOUE, M., TAJIMA, K., HIROSE, K., KUROISHI, T., GAO, C.M. and KITOH, T., Life-style and sub-site of gastric cancer-joint effect of smoking and drinking habits. Int. J. Cancer, 56, 494-499 (1994).
7. KINLEN, L.J., SHEIL, A.G.R., PETO, J. and DOLL, R., Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Brit. med. J.,2, 1461-1466 (1979).
8. KLINTMALM, G.B.M., IWATSUKI, S. and STARZL, T.E., Nephrotoxicity of cyclosporin A in liver- and kidney-transplant patients. Lancer, I, 470-471 (1981).
9. MONSON, R.R., Analysis of relative survival and proportional mortality. Comput. Biomed. Res.,7, 325-332 (1984).
10. OCHIAI, T., ASANO, T. and ISONO, K., Development of malignancies in Japanese renal-transplant recipients. Transplantation Proc.,14, 2967-2970 (1987).
11. PARKIN, D.M., MUIR, C.S., WHELAN, S.L., CAO, Y.T., FERLAY, J. and POWELL, J., Cancer Incidence in Five Continents, Vol. VI, IARC Scientific Publication 120, IARC, Lyon (1992).
12. PENN, I., Depressed immunity and the development of cancer. Cancer Detect. Prevent.,18, 241-252 (1994).
13. RESEARCH GROUP FOR POPULATION-BASED CANCER REGISTRATION IN JAPAN, Cancer incidence and incidence rates in Japan in 1987: estimates based on data from nine population-based cancer registries. Jap. J. Clin. Oncol.,22, 437-442 (1992).
14. TANAKA, K. and 14 OTHERS, Hepatitis C and hepatitis B in the etiology of heputocellular carcinoma in the Japanese population. Cancer Res.,51, 2842-2847 (1991).
15. WATERHOUSE, J., MUIR, C.S., CORREA, P. and POWELL, J., Cancer incidence in five continents. Vol. III, IARC Scientific Publication 15, IARC, Lyon (1976).
16. Yu, M.C., TONG, M.J., COURSAGET, P., Ross, R.K., GOVINDARAJAN, S. and HENDERSON, B.E., Prevalence of hepatitis-B and -C viral markers in black and white patients with hepatocellular carcinoma in the United States. J. nat. Cancer Inst.,82, 1038-1041 (1990).